Modelling the impact of vaccination strategies

Netherlands Journal of Medicine

Volumn 60, Issue 7 SUPPL., 2002, Pages 67-75

  Wallinga, J ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; MEASLES VACCINE; MENINGITIS VACCINE; MENINGOCOCCUS VACCINE; MUMPS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RUBELLA VACCINE; SMALLPOX VACCINE;

ARTICLE; BACTERIAL INFECTION; BACTERIAL MENINGITIS; BORDETELLA PERTUSSIS; CHICKENPOX; CLINICAL OBSERVATION; CORYNEBACTERIUM DIPHTHERIAE; DENMARK; DIPHTHERIA; DISEASE TRANSMISSION; EPIDEMIC; FINLAND; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH PROGRAM; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION SENSITIVITY; LIFE HISTORY; MASS IMMUNIZATION; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; MEASLES; MEASLES VIRUS; MENINGOCOCCOSIS; MICROBIAL IMMUNITY; MUMPS; MUMPS VIRUS; NEISSERIA MENINGITIDIS; NETHERLANDS; PERTUSSIS; POLIOMYELITIS; POLIOMYELITIS VIRUS; RUBELLA; RUBELLA VIRUS; SMALLPOX; SMALLPOX VIRUS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TUBERCULOSIS; VARICELLA ZOSTER VIRUS; BIOLOGICAL MODEL;

DENMARK; FINLAND; HUMANS; MASS IMMUNIZATION; MEASLES; MEASLES VACCINE; MODELS, IMMUNOLOGICAL; NETHERLANDS;

EID: 0036689894     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Panagiotopoulos T, Antoniadou I, Valassi-Adam E. Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review. Br Med J 1999;319:1462-6.
2. Anderson RM, Grenfell BT. Quantitative investigations of different vaccination policies for the control of congenital rubella syndrome (CRS) in the United Kingdom. J Hyg 1986;96:305-33.
3. Kermack WO, McKendrick AG. Contributions to the mathematical theory of epidemics-I. Proc Roy Soc 1927;115a:700-21.
4. Anderson RM, May RM. Directly transmitted infectious diseases: control by vaccination. Science 1982;215:1053-60.
5. Bartlett MS. The critical community size for measles in the United States. JR Statist Soc A 1960;123:37-44.
6. Griffiths DA. The effect of measles vaccination on the incidence of measles in the community. J R Statist Soc A 1973;136:441-9.
7. Anderson RM, May RM. Vaccination and herd immunity to infectious diseases. Nature 1985;318:323-9.
8. Fine PEM, Clarkson JA. The recurrence of whooping cough: possible implications for assessment of vaccine efficacy. Lancet 1982;1:666-9.
9. Cherry JD. Historical review of pertussis and the classical vaccine. J Infect Dis 1998;174(suppl):S259-63.
10. Rohani P, Earn DJD, Grenfell BT. Impact of immunisation on pertussis transmission in England and Wales. Lancet 2000;355:285-6.
11. Gay NJ, Miller E. Pertussis transmission in England and Wales [corresp.]. Lancet 2000;355:1553-4.
12. Quadros CA de, Clivé JM, Hersh BS, et al. Measles elimination in the Americas: evolving strategies. JAMA 1996;275:224-9.
13. Gay NJ, Nokes DJ. JAMA 1996;275:1311-2.
14. Glikmann G, Petersen I, Mordhorst CH. Prevalence of IgG antibodies to mumps and measles virus in non-vaccinated children. Danish Medical Bulletin 1988;35:195-87.
15. Peltola H, Davidkin I, Valle M, et al. No measles in Finland. Lancet 1997;350:1364-5.
16. Hof S van den, Berber GAM, Melker HE de, Conyn-van Spaendonck MAE. Sero-epidemiology of measles antibodies in the Netherlands, a cross-sectional study in an national sample and in communities with low vaccine coverage. Vaccine 2000;18:931-40.